Cysteine proteinases are hypothesized to be important virulence factors of Entamoeba histolytica, the causative agent of amebic dysentery and liver abscesses. The release of a histolytic cysteine proteinase from E. histolytica correlates with the pathogenicity of both axenic strains and recent clinical isolates as determined by clinical history of invasive disease, zymodeme analysis, and cytopathic effect. We now show that pathogenic isolates have a unique cysteine proteinase gene (ACP1). Two other cysteine proteinase genes (ACP2, ACP3) are 85% identical to each other and are present in both pathogenic and nonpathogenic isolates. ACP1 is only 35 and 45% identical in sequence to the two genes found in all isolates and is present on a distinct chromosome-size DNA fragment. Presence of the ACP1 gene correlates with increased proteinase expression and activity in pathogenic isolates as well as cytopathic effect on a fibroblast monolayer, an in vitro assay of virulence. Analysis of the predicted amino acid sequence of the ACP1 proteinase gene reveals homology with cysteine proteinases released by activated macrophages and invasive cancer cells, suggesting an evolutionarily conserved mechanism of tissue invasion. The observation that a histolytic cysteine proteinase gene is present only in pathogenic isolates of E. histolytica suggests that this aspect of virulence in amebiasis is genetically predetermined. (J. Clin. Invest. 1993. 91:1532-1540
Introduction
Entamoeba histolytica infects more than 500 million people worldwide (1) . Almost from the time of its discovery, it was observed that although E. histolytica most often causes mild or asymptomatic infections, -10% of patients develop severe dysentery and life-threatening invasive and extraintestinal disease (2) . Whether these distinct clinical courses represent infection by two different species of Entamoeba (2) or, conversely, whether any strain of E. histolytica can potentially cause disease in the presence of certain environmental factors has been an area of active debate (3, 4) . Distinct isoenzyme patterns (zymodemes) (5) and differences in restriction fragment-length patterns between pathogenic and nonpathogenic strains (6-10) strongly support the premise that the potential to cause invasive disease is genetically determined. If virulence is genetically determined, we would expect a gene encoding a virulence factor that correlated with pathogenicity to be present only in pathogenic strains. We tested this hypothesis using the ameba cysteine proteinase.
Factors associated with the virulence of E. histolytica include surface lectins (1 1, 12) , cytolytic ion channel-forming proteins (13) (14) (15) , phospholipases ( 11 ), and proteinases (10, [16] [17] [18] . The major proteinase of E. histolytica is a cysteine proteinase biochemically similar to cathepsin B (17) (18) (19) (20) . Ex- perimental evidence supporting the role of this cysteine proteinase in the pathogenesis of amebiasis includes its ability to degrade fibronectin, collagen, and basement membrane matrix and to activate the third component of complement (17) (18) (19) 21) . Purified proteinase reproduces the cytopathic effect of pathogenic amebae (17) (18) (19) (20) , and a specific irreversible inhibitor ofthe proteinase prevents destruction of cell monolayers by live axenic amebae (22) . Increased expression and excretion of the proteinase correlates with virulence of both axenic laboratory strains of E. histolytica, and fresh clinical isolates ( 16, 19, 20) . Antibodies to the proteinase were detected in 83% of patients with invasive disease but were not detected in patients with noninvasive infections ( 16) .
Eukaryotic cysteine proteinases have long been recognized as particularly potent proteinases but were best known for their role in intracellular protein digestion (23) . More recently, evidence has accumulated that a subset ofinvasive cancers excrete active or activatable cysteine proteinases. A cathepsin L-like cysteine proteinase is the major excreted protein of transformed fibroblasts (24) (25) (26) . Levels of cathepsin B were found to correlate with the metastatic potential of melanoma variants (24) .
To determine whether the cysteine proteinase released by pathogenic E. histolytica is structurally related to those released by cancer cells and activated macrophages, we used polymerase chain reaction to identify and amplify genes encoding the cysteine proteinases of E. histolytica using primers based on conserved structural motifs of eukaryotic cysteine proteinases (27) . We identified and sequenced three cysteine proteinase genes and now show that one gene is unique to pathogenic isolates of E. histolytica.
Methods
Strains ofE. histolytica. Axenic strain HM-1IMSS was obtained from the American Type Culture Collection (Rockville, MD) and cultured in TYI-S-33 media (28) . Nine pathogenic and 12 nonpathogenic clinical isolates were cultured directly from stools or liver abscesses into Robinson's media as previously described (29 
tat ctt tac aga ttt gct gtt ttc tta gac aac aaa aaa ttt gtt gaa gct aat gct aat act gaa ctt aat gtt ttt ggt gat atg aga gct atc ttC aat atg aat gct aaa ttc gtt gat agt ttc aat aaa att ggt tca ttc aaa tta tca gta gat gga cca ttt gct
act cac gaa gaa ttc atc caa act cat ctt 998 atg act tat gaa gtt cca, gaa act act tct aat gtt aaa gct 9cc gtt aaa gct gct atg act aat gaa gaa tac aga act ctt ctt aaa tct aaa aga act act gaa gaa aat gga caa gtt aaa tat ttq aat atc caa ACP2 
aca, act gca gtt ctt gaa gga aga gtt aac aaa gat ctt 9ga aaa ctt tac tca ttc tct. gaa caa caa tta qtt gat tgt gat tca ctt gca gct. ctt gaa gga aga tta tta att gaa aaa gga ggt gat gct aat aca ctc gat ctt tca gaa gaa cat atg caa tgc 
EK S S Y P Y T S S D S T C K
gtt act gat g98 agt gaa act gga ctt caa act att att gct gaa aac 998 cct gtt gct gtt ggt 8tg gat gct agc 898 cca tca gtc cca aga aac aat gaa gct gaa ctt aaa gct gca ctt tca caa ggt ctt ctt gat gtt tca att gat gtc tca tct gctaa
ttc caa tta tat aag aaa gga act atc tat tct gat act aaa tgt aga tca aga atg atg aat cac t9t gtt act gct gtt ttc caa tta tac 889 agc gga gct tat act Hat act aaa tgc aag aat aac tac ttt gct ttg aat cac gaa gtt tgt gct gtt 
gct 898 gac tcc aac aac 8tg tgt ggt att 998 898 gat tct aac tat cca acc 998 gtc aag tta att taa gtt att 988 998 aat acc -tgt 9gt gtt gct aca gat cca ctt tat cca act ggc gtt caa tat ctt tga The intensity of the resulting bands on autoradiographs was compared by scanning with a Quikscan (Helena Laboratories, Beaumont, TX). Field inversion gel electrophoresis (FIGE). Trophozoites were harvested from early stationary phase cultures and washed twice by centrifugation (10 min at 200 g) in TSE buffer (100 mM NaCI, 50 mM EDTA, 20 mM Tris base, pH 8.0). An equal volume of melted 1.2% InCert Agarose (FMC Corp.) in TSE was added to the parasite pellet.
The mixture was poured into 63-,ul wells of a Hexa-A-Field agarose plug mold (Bethesda Research Laboratories) and allowed to gel at4°C. The agarose blocks were transferred to a tube containing 10 ml of TSE plus 1% N-lauroylsarcosine, 1% Nonidet P-40, and incubated for 3 h with gentle agitation at 4°C. The buffer was then replaced with fresh TSE, 1% N-lauroylsarcosine (TSE-Sarkosyl) and stored at 4°C for a minimum of 18 h. 5 h before use the agarose plugs were transferred to a new tube containing TSE-Sarkosyl with 2 mg/ml Proteinase K and incubated at 45°C.
FIGE was performed in a horizontal electrophoresis unit (model HE 100 SuperSub Hoefer, Scientific Instruments, San Francisco, CA) connected to a PC 750 pulse controller (model PC 750; Hoefer Scientific Instruments). The agarose plugs were loaded into wells of a 1.2% agarose gel (Seakem agarose; FMC Corp.) made with 1.Ox TBE buffer (89 mM Tris base, 89 mM boric acid, 2 mM EDTA, pH 8.0). DNA molecules were separated using two cycles at a constant voltage of 125 V at 8°C in l x TBE buffer. The first cycle was run with a beginning forward pulse of 2.4 s, a reverse pulse of 0.8 with a 1.6 ramp value for 22-24 h. The second cycle lasted 20-24 h with an initial forward pulse of 3.6 s and 1.2 reverse pulse with a 1.6 ramp value. Lambda DNA ladder and Saccharomyces cerevisiae chromosomal DNA (FMC Corp.) were included to estimate the molecular size of the E. histolytica chromosomes. The DNA was depurinated with 0.2 N HCI for 10 min and denatured with 0.5 N NaOH for 45 min before it was transferred to nylon membranes. Hybridizations were performed in 30% formamide, 6x SSPE (sodium chloride, sodium phosphate, EDTA), 5X Denhardt's, 0.2% SDS, and100 jg/ml transfer RNA (tRNA) at 45°C overnight. The filters were washed as described in Sambrook et al. (35) at a final temperature of 68°C for 30 min.
Proteinase purification and peptide sequencing. HM-1 trophozoites were washed and suspended at a concentration of107/ml in PBS and 48.5 KB IFe ide membrane (Immobilon; Millipore Corp., Bedford, MA) by the method ofMatsudaira (36) . Peptide sequencing ofthe amino terminus was performed at the Biomolecular Resource Center at University of California at San Francisco, using a gas phase sequencer (Applied Biosystems Inc., Foster City, CA). Monolayer assayfor cytopathic effect. Trophozoites were purified from xenic media as previously described ( 16) and resuspended in PBS containing 20 mM cysteine, 0. 15 mM CaCl2, and 0.5 mM MgCl2 at a concentration of 107/ml. After incubation for 3 h at 370C, the supernatants were separated and passed through a 0.2-PM filter to remove remaining bacteria from the medium. This procedure did not affect the proteinase activity but was necessary to remove any residual bacterial flora, which is different for each clinical isolate. Proteinase activity was quantified by the cleavage of a synthetic peptide substrate, Z-Arg-Arg-AMC (benzyloxycarbonyl-arginine-arginine-4-amino-7-methylcoumarin) (Enzyme Systems Products, Livermore, CA), as previously described ( 17) , and recorded as the initial velocity of cleavage of the fluorescent 4-amino-7-methylcoumarin/ 10 zd. Proteinase activity was inhibited by preincubating with Z-Phe-Arg-CH2F, an irreversible cysteine proteinase inhibitor (10 gM for 30 min at 370C), which has no effect on the viability of the monolayer (Enzyme Systems Products). 24-well culture plates were seeded with 2 x 105 cells from a foreskin epithelial cell line (HFS 1) and incubated overnight in DME with 10% fetal calf serum in CO2. The medium supplemented with serum was removed and the monolayer washed twice with MEM without sera.
Amebic supernatants ( 100 gl) were added in triplicate to 400 ul of MEM and incubated for 3 h at 37°C with CO2. Detached cells were removed by washing twice with PBS. The remaining cells were fixed (4% Formalin) and quantified by staining with methylene blue dye (0.1% in 0.1 M borate, pH 8.7) and measuring the extracted absorbance at 660 nM (22) . Cytopathic effect (CPE)' was calculated as the absorbance of control wells (MEM alone) minus the absorbance of sample wells divided by control X 100%. To control for variations between different experiments, the values were standardized against the CPE caused by strain HM-1, which was taken as 1.00 (relative CPE). ( 17) . Both the high molecular mass (56 kD) and low molecular mass (27 kD) forms ofthe proteinase were purified. The purified proteinase was subjected to electrophoresis by SDS-PAGE on a 10% gel and transferred to a polyvinylidenedifluorTo isolate the cysteine proteinase genes of E. histolytica, we amplified cysteine proteinase gene fragments by PCR using primers based on conserved structural motifs identified in the eukaryotic cysteine proteinase family (27) . A 450-bp fragment was initially amplified from DNA isolated from the pathogenic axenic strain HM-1, as previously reported (27) . The 450-bp fragment was subsequently used to isolate a genomic clone (ACPl ) containing the entire coding region ofthe mature proteinase (Fig. 1) . A second set of primers based on the amino terminus of this gene and the region around the active site asparagine was then used to amplify two 550-bp genomic fragments ofthe second and third cysteine proteinase genes (ACP2 and ACP3) (Fig. 1) . The (Fig. 2 A) or BglII (3 kb)-(not shown) digested HM-1 genomic DNA whereas ACP2 and ACP3 each hybridized to two larger ( 10 and 12 kb, respectively) EcoRI fragments (Fig. 2 A) . Southern blot analysis after FIGE of HM-1 strain (Fig. 2 B) showed that the ACP1 gene fragment hybridized with two DNA bands of a relative size of -1 Mb and 550 kb.
Results
In contrast, the ACP2 and ACP3 gene fragments hybridized with a single DNA band of relative size 1.9 Mb. FIGE-derived Southern blots hybridized with mixtures of ACP 1 and ACP2 or ACP3 gene fragments (Fig. 2 B, (37) .
To determine whether the presence of any of these genes was correlated with amebic virulence, DNA was extracted from nine pathogenic and nine nonpathogenic clinical isolates classified by their zymodeme patterns and the clinical syndrome of the patients (5) . In Southern blot analysis of EcoRI-digested DNA from all nine pathogenic isolates, ACP1 hybridized to a 2.1-2.3-kb fragment, similar to that seen in the digest of HM-I DNA. It did not hybridize to any DNA fragment from any of the nine nonpathogenic isolates (Fig. 3 A) (Fig. 3 B) . Because complete genomic clones of ACP2 and ACP3 were not available, it is difficult to assign specific map positions to the fragments in Fig. 3 (Fig. 4 A) . When the same blot was hybridized with the ACP2 probe, a band of equivalent intensity and identical molecular weight was observed with all strains. The ACP3 probe also hybridized to a band of identical size in all three pathogenic and four nonpathogenic RNA samples tested (not shown). These Northern blots suggested that ACP2 and ACP3 were expressed in all isolates whereas ACP1 was expressed only in pathogenic isolates but crosshybridized weakly with the other genes (faint bands in nonpathogenic lanes in Fig. 4 A) . To confirm this result with a more sensitive measure of potentially low abundance mRNAs, ribonuclease protection assays were performed using antisense RNA transcripts synthesized from ACP1 and ACP2. A 1.2-kb band was detected in all isolates with the ACP2 probe whereas the ACP1 probe hybridized strongly only with transcripts from the pathogenic isolates (Fig. 
C).
To directly correlate the presence of the ACP1 gene in pathogenic amebae with enhanced proteinase activity and a quantitative assay of virulence, the total cysteine proteinase activity ofamebic supernatants was determined and correlated in the same ameba isolates with the cytopathic effect on a fibroblast cell monolayer. The proteinase activity (initial velocity/ 10 Al) of five pathogenic strains containing ACP1 was significantly greater than that offour nonpathogenic strains lacking it (P < 0.03) (Fig. 5) . The relative CPE (corrected to that of HM-1 as 1.00) by pathogenic strains was also significantly greater (P < 0.001 ) and was completely inhibited, as demonstrated previously (22) , by preincubation with 100 ,AM Z-PheArg-CH2F, an irreversible and specific cysteine proteinase inhibitor. Furthermore, the enhanced proteinase activity correlated with elevated cysteine proteinase mRNA in the pathogenic versus nonpathogenic isolates (Fig. 5) . In summary, Fig. 5 shows that the presence of an additional cysteine proteinase gene (ACPl ) in pathogenic isolates correlates with increased proteinase mRNA, increased proteinase activity, and (Fig. 6) . Specifically, all three amino acid residues of the catalytic triad of cysteine proteinases (cysteine, histidine, and asparagine) were present, and structural motifs flanking these residues were highly conserved (Fig. 6 ).
Discussion
The potential multifactorial roles of cysteine proteinases in invasion of pathogenic amebae are well documented (16) (17) (18) (19) (20) (21) (22) . They include degradation of host extracellular matrix and mucoproteins, dislodgment of epithelial cells and degradation of epithelial basement membrane, and possibly recruitment of inflammatory cells to sites of ameba invasion by activation of complement.
We have now shown that the enhanced expression and release of cysteine proteinase activity by virulent laboratory strains ( 17, 20) and pathogenic clinical isolates ( 16) correlates with the presence ofa unique cysteine proteinase gene (ACP 1), which was not detected in Southern blots ofDNA ofnonpathogenic amebae. Tannich et al. ( 10) also identified restriction fragment-length polymorphisms between pathogenic and nonpathogenic strains by hybridization with two other cysteine proteinase genes. One of these genes (cEh-CPnp) may correspond to ACP2 and the other (cEh-CPp) is identical to ACP3. However, our examination of a larger set of clinical isolates suggests that neither of these latter two closely related genes is unique to nonpathogenic or pathogenic amebae (Fig. 2) . We speculate that ACP2 and ACP3 arose from copies of the same gene and remain closely linked on one chromosome. Their presence in both pathogenic and nonpathogenic isolates of E. histolytica suggests they may play a role in basic metabolism of amebae, most likely intracellular protein degradation. ACP1 is quite divergent in sequence from ACP2 and ACP3, and copies of the ACP1 gene are present on different chromosome-sized DNA fragments than ACP2 and ACP3 (Fig. 2 B) . Nevertheless, the data from both studies presented here together with those reported by Tannich et al. ( 10) are consistent with the presence of an additional cysteine proteinase gene in pathogenic strains, resulting in increased cysteine proteinase mRNA and consequently higher levels of extracellular proteolytic activity. Our observation that amino-terminal sequencing of the E. histolytica cysteine proteinase yields more than one signal (APE [S] K[A] . .) also supports the hypothesis that the enhanced production and release of cysteine proteinases by virulent E. histolytica is due to the presence and expression of multiple genes. Although our Southern blot analysis (Fig. 3 A) suggested that the ACP1 gene was unique to pathogenic isolates, Orozco (38) has offered an alternative explanation for these results. She speculates that gene amplification may lead to enhanced expression ofvirulence factors in pathogenic amebae. We cannot exclude the possibility that our hybridization conditions did not identify a single copy ofACP I in nonpathogenic isolates and that the gene is highly amplified in pathogenic DNA, leading to enhanced cysteine proteinase expression. In fact, the results of varying EcoRI digestion conditions (0. 1-8 U of enzyme) suggested that multiple tandem copies of ACP1 were present. FIGE also suggested that there were at least two distinct chromosome locations for ACP 1 gene copies (Fig.  2 B) . In either case, we speculate that in pathogenic isolates the expression of the ACP1 gene(s) in addition to expression of ACP2 and ACP3 genes results in extracellular proteinase activity exceeding a critical threshold, which, coupled with other virulence factors ( 1 1-18 teine proteinase release by pathogenic amebae. In each case, cysteine proteinases are found both in intracellular digestive organelles as well as released extracellularly in multiple molecular forms, including active or activatable proenzymes ( 17, (24) (25) (26) . Like the targeting of cysteine proteinases to lysosomes or endosomes in mammalian cells, the cysteine proteinases of both pathogenic and nonpathogenic strains of E. histolytica appear to be targeted at least in part to endosome-like cytoplasmic vacuoles where endocytosed bacteria and cells are degraded (39) . Default secretion due to alterations in mannose-6-phosphate containing signal moieties or transcriptional overexpression of specific proteinase genes are two mechanisms by which transformed mammalian cells are thought to release lysosomal cysteine proteinases into the extracellular milieu (26) .
In amebae there is a correlation between elevated rates of phagocytosis and virulence (40) , and phagocytosis-deficient mutants release less extracellular cysteine proteinase (22) . The adaptive advantage for the pathogenic amebae ofan additional cysteine proteinase gene and, consequently, higher levels of extracellular cysteine proteinase may therefore be related to enhanced phagocytosis and/or extracellular digestion ofbacteria and cells. At this time we cannot exclude the possibility that the differences in the coding sequence ofthe three cysteine proteinase genes of E. histolytica might reflect distinct transport or biochemical properties. However, at least the specificity for synthetic peptide substrates among the three gene products appears to be identical (17) (18) (19) (20) and, unlike their mammalian counterparts, none of the ameba cysteine proteinases contain asparagine-linked carbohydrate addition sites for mannose-6-phosphate lysosome targeting signals (Fig. 6) (10) .
All previous studies of virulence have used axenized pathogenic strains that have become attenuated to varying degrees during cultivation. A direct comparison to nonpathogenic strains has not been possible because these strains have never been axenized. On the basis of the observations reported here, we can now confirm that there are quantitative differences in CPE between authentic pathogenic and nonpathogenic clinical isolates, which in turn correlate with the presence ofthe ACP1 gene in pathogenic strains and enhanced proteinase release (Fig. 5) . Noteworthy, however, is the observation that CPE is not totally absent in nonpathogenic isolates and therefore cannot be used alone as an assay ofpathogenicity, as was suggested by its historical use with axenic strains. We also confirm previous studies (22) that CPE is inhibited by a specific inhibitor of cysteine proteinases.
It is likely that host immune status, nutritional status, and associated intestinal bacteria influence susceptibility to colonization and invasion by E. histolytica. However, our identification of a cysteine proteinase gene that is specific to pathogenic strains and correlates with increased extracellular proteinase activity argues strongly that the potential for pathogenicity is an intrinsic property of the organism.
